General Information of the Compound
Compound ID
CP0848635
Compound Name
rac-2-(4-{2-[4-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-2-propoxyphenyl]ethyl}benzyl)butyric acid
    Show/Hide
Structure
Formula
C30H31NO5
Molecular Weight
485.58
Canonical SMILES
CCCOc1cc(N2C(=O)c3ccccc3C2=O)ccc1CCc1ccc(CC(CC)C(=O)O)cc1
    Show/Hide
InChI
InChI=1S/C30H31NO5/c1-3-17-36-27-19-24(31-28(32)25-7-5-6-8-26(25)29(31)33)16-15-23(27)14-13-20-9-11-21(12-10-20)18-22(4-2)30(34)35/h5-12,15-16,19,22H,3-4,13-14,17-18H2,1-2H3,(H,34,35)
    Show/Hide
InChIKey
ZPSPDBLGNWMFEX-UHFFFAOYSA-N
Physicochemical Property
logP
5.7145
Rotatable Bonds
11
Heavy Atom Count
36
Polar Areas
83.91
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
36

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 56669682
ChEMBL ID
CHEMBL1813198
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00910, Peroxisome proliferator-activated receptor alpha
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
EC50 = 1700 nM
   TI
   LI
   LO
   TS
Protein ID: PT00909, Peroxisome proliferator-activated receptor delta
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
EC50 = 2900 nM
   TI
   LI
   LO
   TS
Protein ID: PT00915, Peroxisome proliferator-activated receptor gamma
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
EC50 = 6900 nM
   TI
   LI
   LO
   TS